Clinical Resources: Standing Orders Templates

Results (41)

Standing Orders for Administering 2025-2026 Formula Adjuvanted Protein COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer Nuvaxovid (Sanofi-Novavax) COVID-19 vaccine to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3141
Updated on: 11/13/25
Language: English

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Children 6 Months through 11 Years

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to children 6 months through 11 years, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, and IDSA are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3140a
Updated on: 11/13/25
Language: English

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3140
Updated on: 11/13/25
Language: English

This page was updated on .